Navigation Links
Central Florida Pain Relief Expert Dr. Avi Bhandary Gives Patients Their Life Back with BOTOX®
Date:5/29/2013

Orlando, FL (PRWEB) May 29, 2013

Dr. Avi Bhandary of Rehabilitation Medical Group, a leading comprehensive pain management practice in Central Florida, is giving patients their life back through the FDA-approved use of BOTOX® (Botulinum toxin A) as a preventative treatment for chronic migraines.

Sharon and Meghan McGinnis have suffered from chronic migraines for most of their lives. The mother and daughter said they have tried nearly everything for relief, but only one thing has worked for them – BOTOX®. “This finally gave us our life back,” Meghan McGinnis said. “We’ve been telling anybody that has migraines, ‘You’ve got to go try this.’”

The Food and Drug Administration approved BOTOX® injections for migraine treatment in 2010, after clinical studies funded by Allergan, Inc. produced evidence that patients showed improvement in incidence of chronic migraines for migraine sufferers receiving the BOTOX® treatment. Several trials since have shown Botulinum toxin A improves headache symptoms and quality of life when used as a preventative treatment for migraines.

“When you can promise a patient who has suffered with chronic migraines headache-free days, that's something that means a lot to them,” Bhandary said. Patients suffering from chronic migraines experience symptoms including light-sensitivity, nausea and vomiting, blurred vision or vision loss, and pulsating or throbbing pain. For some patients these symptoms, and the chronic nature of their migraines, are so severe that daily activities such as working become difficult, if not impossible.

Migraine treatment options include pain-relieving prescription medications from Triptans such as Imitrex®, to anti-nausea medications and opiates. These medications are designed to treat the symptoms of migraines, and though effective, often come with side effects that pose problems for patients longer-term. “BOTOX relaxes the muscles and reduces contractions, stopping migraines before they start,” Dr. Bhandary said. “For some patients, this is a quality of life they never knew was possible.”

For migraine patient Meghan McGinnis, “This is different - this is what normal feels like.” Dr. Bhandary’s insight, clinical skill, and knowledge of the use of Botulinum toxin A for the therapeutic treatment of chronic migraines, is giving migraine patients in Central Florida new hope.

About Dr. Bhandary:
Dr. Avi Bhandary is an award-winning physician who joined Dr. Michael Creamer, one of Orlando’s most experienced interventional physicians, at Rehabilitation Medical Group (RMG) in 2012. Dr. Bhandary’s extensive experience with Botulinum toxin A is a result of his training at the University of Pittsburgh, working with stroke related spasticity and children afflicted with Cerebral Palsy. Patients can see Dr. Bhandary at Rehabilitation Medical Group to evaluate headache symptoms, assess and potentially rule out possible underlying factors such as cervical spine disorders, and receive expert opinion on the safety and efficacy of Botulinum toxin A for the treatment of migraines and spasticity. Rehabilitation Medical Group physicians hold certifications in the field of Pain Medicine, as well as Physical Medicine and Rehabilitation. RMG provides patients in Central Florida with customized care plans that emphasize independence, comfort and the maintenance of functionality, working to eliminate over-dependence on prescription pain medications.

Read the full story at http://www.prweb.com/releases/BotoxForMigraines/BhandaryRMGOrlando/prweb10768590.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. KORT's Athletic Training Program at Central High School Sends Student to National Health Sciences Competition
2. Preferred retinal location may aid rehabilitation in patients with central vision loss
3. Baldrige Award Winner Southcentral Foundation Selects i2iTracks Population Health Intelligence Solution to Support Meaningful Use, GPRA and UDS Reporting Requirements
4. Hound.com Finds Jobs in South Atlantic and South West Central Regions Mirroring Current Employment Trends
5. Central Oregon Management Consultant Earns TIGERS Success Series Team Development and Team Effectiveness Certification and Licensing
6. Central Marketplace, Inc. Launches Website Featuring AllerAir Air Purifiers
7. Study finds key protein for firing up central nervous system inflammation
8. Online Birkenstock Store BirkenstockCentral.com is offering Life is good® Limited Edition Boston Love Tee Shirt
9. Mom Central Bloggers to Get a Sneak Peak at the New and Improved Adult Essentials Multi Vitamin Gummies
10. Medistra Hospital, Jakarta Becomes First Hospital in Indonesia with Centralized Image Archive
11. WINFertility Treatment Program Expands to Central/Southern Texas. Program Makes IVF Treatment More Affordable for Patients Without Infertility Insurance Coverage.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... “The Journey: ... faced every danger possible to save lost souls in the Philippines. “The Journey: From ... Carole is a dedicated teacher of the Bible. She has taught all ages and ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and ... apnea using cutting-edge Oventus O2Vent technology. As many as 18 million Americans ... frequent cessation in breathing. Oral appliances can offer significant relief to about 75 ...
(Date:10/12/2017)... ... 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ), one of the ... new design of the shoulder pad. The shoulder pad provides optimal support and ... pain while using cold therapy. By utilizing ice and water that is circulated from ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... drug delivery system that we intend to develop to enable prevention of a ... lead to severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at ... D.C., for the 49th Congress of the International Society of Paediatric Oncology ... the Center for Cancer and Blood Disorders at Children’s National, and Stephen ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... -- Diplomat Pharmacy, Inc. (NYSE: DPLO ) ... , and named its founder as Diplomat,s chief information ... Tennessee , will operate under Diplomat subsidiary Envoy ... for health care partners to include IT outsourcing, consulting, ... "In an interoperable world, technology delivers comprehensive insight and ...
(Date:9/28/2017)... , Sept. 28, 2017 Hill-Rom Holdings, ... 2017 earnings conference call and webcast on Friday, November ... a.m. (EDT) and ending at approximately 8:30 a.m. (CDT) ... discussing the company,s 2017 financial performance and guidance for ... opportunities, initiatives to enhance operational performance, and long-range financial ...
(Date:9/25/2017)... R.I. , Sept. 25, 2017  EpiVax, ... assessment, vaccine design, and immune-engineering today announced the ... on the development of personalized therapeutic cancer vaccines. ... has provided exclusive access to enabling technologies to ... Eng., MBA will lead EpiVax Oncology as Chief ...
Breaking Medicine Technology: